David Kent

545 total citations
18 papers, 439 citations indexed

About

David Kent is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Kent has authored 18 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Ophthalmology, 11 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Kent's work include Retinal Diseases and Treatments (12 papers), Retinal Development and Disorders (7 papers) and Glaucoma and retinal disorders (5 papers). David Kent is often cited by papers focused on Retinal Diseases and Treatments (12 papers), Retinal Development and Disorders (7 papers) and Glaucoma and retinal disorders (5 papers). David Kent collaborates with scholars based in United Kingdom, United States and Ireland. David Kent's co-authors include Carl Sheridan, Paul Hiscott, David Wong, David M. Pattwell, Ian Grierson, Rachel Williams, Yamini Krishna, Maria B. Grant, Gautam Behl and Órla O’Donovan and has published in prestigious journals such as SHILAP Revista de lepidopterología, The FASEB Journal and Investigative Ophthalmology & Visual Science.

In The Last Decade

David Kent

18 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Kent United Kingdom	11	274	214	167	36	27	18	439
Peter Lundh von Leithner United Kingdom	8	359 1.3×	251 1.2×	240 1.4×	10 0.3×	9 0.3×	10	490
Wenzheng Hu United States	9	305 1.1×	304 1.4×	126 0.8×	26 0.7×	8 0.3×	18	473
Lucía González-Buendía Spain	8	291 1.1×	123 0.6×	264 1.6×	23 0.6×	7 0.3×	19	416
Iris Navarro United States	14	402 1.5×	297 1.4×	155 0.9×	39 1.1×	6 0.2×	21	591
Santiago Delgado‐Tirado Spain	7	259 0.9×	112 0.5×	244 1.5×	23 0.6×	8 0.3×	14	372
Noboru Arimura Japan	15	517 1.9×	184 0.9×	391 2.3×	20 0.6×	8 0.3×	20	787
David Urech Switzerland	10	140 0.5×	187 0.9×	152 0.9×	5 0.1×	23 0.9×	14	394
Ester Reina‐Torres United Kingdom	12	313 1.1×	166 0.8×	160 1.0×	13 0.4×	4 0.1×	17	486
LanHsin Liu United States	6	159 0.6×	214 1.0×	133 0.8×	20 0.6×	3 0.1×	9	343
Mercy Pawar United States	10	85 0.3×	193 0.9×	34 0.2×	50 1.4×	7 0.3×	25	288

Countries citing papers authored by David Kent

Since Specialization

Citations

This map shows the geographic impact of David Kent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kent more than expected).

Fields of papers citing papers by David Kent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Kent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kent. The network helps show where David Kent may publish in the future.

Co-authorship network of co-authors of David Kent

This figure shows the co-authorship network connecting the top 25 collaborators of David Kent. A scholar is included among the top collaborators of David Kent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Kent. David Kent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Berger, Brian B., et al.. (2024). CANBERRA: A Phase II Randomized Clinical Trial to Test the Therapeutic Potential of Oral Vicasinabin in Diabetic Retinopathy. SHILAP Revista de lepidopterología. 5(2). 100650–100650. 1 indexed citations

2.

Kumari, Sangeeta, Sweta Rani, Gautam Behl, et al.. (2021). Dexamethasone-Loaded Nanostructured Lipid Carriers for the Treatment of Dry Eye Disease. Pharmaceutics. 13(6). 905–905. 36 indexed citations

3.

Luttrull, Jeffrey K., et al.. (2020). <p>Slowed Progression of Age-Related Geographic Atrophy Following Subthreshold Laser</p>. Clinical ophthalmology. Volume 14. 2983–2993. 13 indexed citations

4.

Caballero, Sergio, David Kent, Nilanjana Sengupta, et al.. (2017). Bone Marrow–Derived Cell Recruitment to the Neurosensory Retina and Retinal Pigment Epithelial Cell Layer Following Subthreshold Retinal Phototherapy. PMC. 1 indexed citations

5.

Caballero, Sergio, David Kent, Nilanjana Sengupta, et al.. (2017). Bone Marrow–Derived Cell Recruitment to the Neurosensory Retina and Retinal Pigment Epithelial Cell Layer Following Subthreshold Retinal Phototherapy. Investigative Ophthalmology & Visual Science. 58(12). 5164–5164. 22 indexed citations

6.

Reynolds, Alison, David Kent, & Breandán N. Kennedy. (2014). Current and Emerging Therapies for Ocular Neovascularisation. Advances in experimental medicine and biology. 801. 797–804. 2 indexed citations

7.

Kent, David. (2014). Age-related macular degeneration: beyond anti-angiogenesis.. PubMed. 20. 46–55. 29 indexed citations

8.

Calzi, Sergio Li, David Kent, Kyung Hee Chang, et al.. (2009). Labeling of stem cells with monocrystalline iron oxide for tracking and localization by magnetic resonance imaging. Microvascular Research. 78(1). 132–139. 16 indexed citations

9.

Sheridan, Carl, et al.. (2009). Expression of hypoxia-inducible factor−1α and −2α in human choroidal neovascular membranes. Graefe s Archive for Clinical and Experimental Ophthalmology. 247(10). 1361–1367. 75 indexed citations

10.

Jarajapu, Yagna, et al.. (2009). Inhibition of NADPH oxidase restores NO availability and migratory function in diabetic CD34 cells. The FASEB Journal. 23(S1). 1 indexed citations

11.

Sheridan, Carl, et al.. (2007). SDF1-alpha is associated with VEGFR-2 in human choroidal neovascularisation. Microvascular Research. 75(3). 302–307. 25 indexed citations

12.

Sheridan, Carl, Yamini Krishna, Rachel Williams, et al.. (2007). Transplantation in the treatment of age-related macular degeneration: past, present and future directions. Expert Review of Ophthalmology. 2(3). 497–511. 6 indexed citations

13.

Sahni, Jayashree, et al.. (2006). Optical coherence tomography analysis of bilateral end‐stage choroidal neovascularization where one eye is treated with photodynamic therapy. Clinical and Experimental Ophthalmology. 35(1). 13–17. 5 indexed citations

14.

Krishna, Yamini, Carl Sheridan, David Kent, Ian Grierson, & Rachel Williams. (2006). Polydimethylsiloxane as a substrate for retinal pigment epithelial cell growth. Journal of Biomedical Materials Research Part A. 80A(3). 669–678. 32 indexed citations

15.

Sheridan, Carl, et al.. (2006). The Presence of AC133-Positive Cells Suggests a Possible Role of Endothelial Progenitor Cells in the Formation of Choroidal Neovascularization. Investigative Ophthalmology & Visual Science. 47(4). 1642–1642. 47 indexed citations

16.

Kent, David, Carl Sheridan, Sarah White, et al.. (2003). Edible mushroom (Agaricus bisporus) lectin inhibits human retinal pigment epithelial cell proliferation in vitro. Wound Repair and Regeneration. 11(4). 285–291. 23 indexed citations

17.

Kent, David, Gildo Y Fujii, Dante J. Pieramici, et al.. (2003). ANGIOGRAPHIC CHARACTERISTICS IN PATIENTS UNDERGOING MACULAR TRANSLOCATION FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION. Retina. 23(2). 152–158. 3 indexed citations

18.

Kent, David & Carl Sheridan. (2003). Choroidal neovascularization: a wound healing perspective.. PubMed. 9. 747–55. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact